ライフサイエンスコーパス: coronary bypass

1 The risk of emergency coronary bypass also was reduced by stenting (0.3% vs. 0

2 manifesting a steeper rise after age 75 for coronary bypass and approaching octogenarian age for iso

3 do AVR, the rest were combination surgeries (coronary bypass and/or aortic surgeries).

4 ry (36% isolated AV surgery, 16% concomitant coronary bypass, and 58% aortic replacement), and 262 pa

5 on, percutaneous coronary intervention, redo coronary bypass, and the composite of all events identif

6 gery, 88.3%; aortic valve replacement, 4.5%; coronary bypass + aortic valve replacement, 7.1%) had ri

7 utcome assessment, and also the dominance of coronary bypass being threatened by the success of inter

8 Combined coronary bypass (CABG) and mitral procedures have been a

9 severe left ventricular dysfunction, repeat coronary bypass carries a higher surgical mortality than

10 onsecutive patients who received the RA as a coronary bypass conduit at our institution.

11 The RA is becoming a recognized alternative coronary bypass conduit.

12 Five years after surgery, RA coronary bypass conduits grafted to a single coronary te

13 t early and late occlusion of saphenous vein coronary bypass conduits.

14 evolution in cardiac surgical techniques for coronary bypass graft (CABG) surgery has occurred.

15 rals on myocardial functional recovery after coronary bypass graft (CABG) surgery in a group of patie

16 previous myocardial infarction (MI) (45.8%), coronary bypass graft surgery (39.2%), chronic renal fai

17 ransluminal coronary angioplasty (PTCA), and coronary bypass graft surgery (CABG).

18 aneous transluminal coronary angioplasty and coronary bypass graft surgery in patients with symptomat

19 An acute renal event after coronary bypass graft surgery is associated with high mo

20 Trial randomized patients with a history of coronary bypass graft surgery to either an aggressive or

21 nd descriptive study of 4801 patients having coronary bypass graft surgery with cardiopulmonary bypas

22 race, treatment assignment, and years since coronary bypass graft surgery, a CES-D score > or =16 wa

23 efore the AMI, younger age, history of prior coronary bypass graft surgery, and non-white race.

24 ortality and morbidity compared with on-pump coronary bypass graft surgery.

25 t who had received blood transfusions during coronary bypass grafting 9 years earlier.

26 , and at 2, 4, 12, and 20 hrs after elective coronary bypass grafting in 31 patients.

27 Revascularization with coronary bypass grafting or percutaneous coronary interv

28 herapy of atrial fibrillation concomitant to coronary bypass grafting using epicardial Ultrasound tec

29 n (mean LVEF, 24.0%; SD, 8.3%) scheduled for coronary bypass grafting were recruited.

30 ion fraction) and women (age and concomitant coronary bypass grafting).

31 were obtained in 15 male patients undergoing coronary bypass grafting, all with normal left ventricul

32 arterial disease, previous stroke, previous coronary bypass grafting, heart failure, and renal dysfu

33 branches or adjacent arch vessels, and 3 had coronary bypass grafting.

34 uld suggest more natural ways of engineering coronary bypass grafts and revascularizing the heart.

35 uring stenting of degenerated saphenous vein coronary bypass grafts are reduced, but not eliminated,

36 long-term patency of internal mammary artery coronary bypass grafts compared with venous grafts has b

37 Degeneration of saphenous vein coronary bypass grafts has become a common problem.

38 Additionally, all coronary bypass grafts were rated as patent or occluded.

39 71%) were undergoing reoperation with patent coronary bypass grafts, and 5 (16%) had a porcelain asce

40 peripheral arterial disease, saphenous vein coronary bypass grafts, and diabetic retinopathy.

41 reatment for stenotic saphenous venous aorto-coronary bypass grafts, but their placement carries a 20

42 Patients with coronary bypass grafts, chronic total occlusions, and th

43 omyopathy, angina, heart transplantation and coronary bypass grafts, coronary artery disease, diabeti

44 As compared with saphenous-vein coronary bypass grafts, internal-thoracic-artery grafts

45 eater than 74, 78, and 75 years for isolated coronary bypass, isolated valve surgery, and coronary by

46 d perfusion during minimally invasive direct coronary bypass (MIDCAB).

47 natherosclerotic repair arteries gathered at coronary bypass operations from 30 patients with type 2

48 We reviewed 9442 isolated coronary bypass operations performed from 1989 through 1

49 on (MI); angina pectoris; and performance of coronary bypass or angioplasty.

50 early morbidity and mortality in reoperative coronary bypass patients with a reduced EF (<36%).

51 coronary bypass, isolated valve surgery, and coronary bypass plus valve surgery, respectively.

52 22 patients with severe saphenous vein aorto-coronary bypass stenoses.

53 ngioplasty (32.5% versus 13.2%, P<.0001), or coronary bypass surgery (12.5% versus 9.5%, P<.0001).

54 e were obtained from 386 patients undergoing coronary bypass surgery (127 with type 2 diabetes).

55 ervention (32.1% versus 23.8%; P<0.001), and coronary bypass surgery (9.2% versus 5.7%; P<0.001).

56 al artery in 53 patients who were undergoing coronary bypass surgery (age 60+/-11 years; 13% female).

57 Coronary bypass surgery (CABG) and angioplasty (PTCA) ha

58 based secondary preventive medications after coronary bypass surgery (CABG) and percutaneous coronary

59 se saphenous vein grafts to the aorta during coronary bypass surgery (CABG) without cross-clamping.

60 grafting (re-CABG) in patients with previous coronary bypass surgery (CABG).

61 of initial coronary angioplasty (n = 198) or coronary bypass surgery (n = 194) for patients with mult

62 k 6 weeks sooner than patients who underwent coronary bypass surgery (P < 0.001), but long-term emplo

63 ce interval, 0.56 to 0.81], respectively) or coronary bypass surgery (relative risk, 0.72 [95 percent

64 nsmural endomyocardial biopsy at the time of coronary bypass surgery (two biopsies per patient for a

65 ong-term cognitive function is similar after coronary bypass surgery and coronary angioplasty in the

66 ss repeat interventions, in particular, less coronary bypass surgery and have similar long-term survi

67 e neointima formation in vein grafts used in coronary bypass surgery and in improving methods of myoc

68 en aspirin usage within the 5 days preceding coronary bypass surgery and risk of adverse in-hospital

69 Off-pump coronary bypass surgery and the newest generation of dru

70 Two other deaths occurred, one after coronary bypass surgery and the other from hepatic failu

71 larization via percutaneous interventions or coronary bypass surgery are appropriate in specific case

72 ute changes in renal function after elective coronary bypass surgery are incompletely characterized a

73 Adverse cerebral outcomes after coronary bypass surgery are relatively common and seriou

74 tients, patients are referred frequently for coronary bypass surgery because of residual thrombus and

75 death, myocardial infarction, and emergency coronary bypass surgery combined was lower (4.9% versus

76 emilofiban there was 1 death after emergency coronary bypass surgery complicated by severe bleeding d

77 pare percutaneous coronary intervention with coronary bypass surgery for multivessel coronary disease

78 The risk of atrial fibrillation (AF) after coronary bypass surgery has been related to redox state,

79 r viability preoperatively who still undergo coronary bypass surgery have a high rate of early and la

80 on by percutaneous coronary interventions or coronary bypass surgery have been shown to improve outco

81 repeat angioplasty in 28 patients (28%) and coronary bypass surgery in 2 patients (2%); the overall

82 cal trial of robotically assisted endoscopic coronary bypass surgery in the United States showed favo

83 changes in cerebral function after elective coronary bypass surgery is a difficult clinical problem.

84 Whether PTCA or coronary bypass surgery is more suitable for these patie

85 Early use of aspirin after coronary bypass surgery is safe and is associated with a

86 Coronary bypass surgery often leads to short-term cognit

87 re, 75 (61.5%) had PTCA only, 30 (24.6%) had coronary bypass surgery only, and 17 (13.9%) had both pr

88 sease in patients who are not candidates for coronary bypass surgery or angioplasty.

89 Coronary bypass surgery or balloon angioplasty.

90 e and a potential viable alternative to open coronary bypass surgery or multivessel stenting.

91 plantation with no antiarrhythmic therapy in coronary bypass surgery patients who had a left ventricu

92 ects with DPT had a more frequent history of coronary bypass surgery than referents (19% versus 2%; p

93 -old man developed acute renal failure after coronary bypass surgery that had been complicated by ste

94 ts, myocardial biopsies were obtained during coronary bypass surgery to assess glucose transporter (G

95 nated comparative information on outcomes of coronary bypass surgery to the public.

96 of this study was to evaluate outcomes after coronary bypass surgery versus coronary angioplasty in 5

97 farction, repeated coronary angioplasty, and coronary bypass surgery was determined for 479 patients

98 Coronary bypass surgery was needed in 7.5 percent of the

99 ative quantitative 201Tl scintigraphy before coronary bypass surgery were analyzed retrospectively.

100 biopsy specimens from 37 patients undergoing coronary bypass surgery were collected.

101 ng concomitant cardiac operations except for coronary bypass surgery were excluded.

102 vessel segments from 19 patients undergoing coronary bypass surgery were incubated with or without c

103 ive heart failure, myocardial infarction, or coronary bypass surgery were less likely to receive repe

104 articular the internal mammary arteries, for coronary bypass surgery whenever possible.

105 ocedures (coronary angioplasty, stenting, or coronary bypass surgery) performed by individual practit

106 mbosis; saphenous vein graft occlusion after coronary bypass surgery), and particularly those with di

107 of myocardial infarction was 2.7%; emergency coronary bypass surgery, 1.4%; and death, 0.5%.

108 Among patients with diabetes, previous coronary bypass surgery, as compared with coronary angio

109 hibernation and may still be candidates for coronary bypass surgery, even in the absence of angina.

110 with inducible ischemia were revascularized (coronary bypass surgery, n = 67 or angioplasty, n = 11).

111 ospectively studied 5065 patients undergoing coronary bypass surgery, of whom 5022 survived the first

112 patients were free of myocardial infarction, coronary bypass surgery, or additional percutaneous inte

113 e death, all myocardial infarction, emergent coronary bypass surgery, or clinically indicated target

114 ted with improved ventricular function after coronary bypass surgery, the relationship between viabil

115 eath (0.5%), and 2 patients (0.9%) underwent coronary bypass surgery.

116 8 +/- 5 weeks after myocardial infarction or coronary bypass surgery.

117 urvival benefit of BIMA up to 10 years after coronary bypass surgery.

118 rsus closed tunnel endoscopic harvesting for coronary bypass surgery.

119 LV biopsy samples were obtained during coronary bypass surgery.

120 ubjected to cardiac ischemia, such as during coronary bypass surgery.

121 uce the risk of complications or death after coronary bypass surgery.

122 and thallium-201 ((201)Tl) tomography before coronary bypass surgery.

123 on (MI), 32% had prior PCI and 19% had prior coronary bypass surgery.

124 nt with aspirin could improve survival after coronary bypass surgery.

125 cost are less than for conventional repeated coronary bypass surgery.

126 causing suboptimal myocardial function after coronary bypass surgery.

127 shorter convalescence than those who undergo coronary bypass surgery.

128 y angioplasty: OR 0.60, 95% CI 0.25 to 1.49; coronary bypass surgery: OR 0.22, 95% CI 0.08 to 0.63; a

129 ts, five were treated medically and one with coronary bypass surgery; three died.

130 ry of coronary-artery disease, hypertension, coronary-bypass surgery and cerebral ischaemia, smoking

131 immediate Palmaz-Schatz coronary stenting of coronary bypass vein grafts.

132 ion by percutaneous coronary intervention or coronary bypass was lower in DES patients (adjusted HR 0